 Jonathan Roach
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 6 | 2022 | 160 | 1.900 |
Why?
| | Medical Errors | 2 | 2025 | 104 | 1.460 |
Why?
| | Specialties, Surgical | 2 | 2022 | 73 | 1.310 |
Why?
| | Liver Neoplasms | 9 | 2024 | 633 | 1.250 |
Why?
| | Hepatoblastoma | 6 | 2024 | 41 | 1.110 |
Why?
| | Surgical Oncology | 6 | 2024 | 22 | 1.040 |
Why?
| | Liver Transplantation | 6 | 2024 | 798 | 0.980 |
Why?
| | Appointments and Schedules | 1 | 2025 | 82 | 0.920 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 97 | 0.860 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2024 | 60 | 0.850 |
Why?
| | Adrenocortical Carcinoma | 1 | 2024 | 63 | 0.850 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2024 | 270 | 0.740 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 45 | 0.730 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 194 | 0.620 |
Why?
| | Cholestasis | 1 | 2020 | 228 | 0.570 |
Why?
| | Quality Improvement | 2 | 2025 | 1094 | 0.560 |
Why?
| | Child | 30 | 2025 | 20655 | 0.550 |
Why?
| | Kidney Neoplasms | 4 | 2023 | 349 | 0.520 |
Why?
| | Appendectomy | 3 | 2023 | 76 | 0.510 |
Why?
| | Neoplasms | 3 | 2025 | 2464 | 0.510 |
Why?
| | Patient Safety | 1 | 2019 | 287 | 0.500 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 272 | 0.500 |
Why?
| | Pediatrics | 2 | 2024 | 1046 | 0.490 |
Why?
| | Surgeons | 1 | 2019 | 259 | 0.480 |
Why?
| | Accidents | 1 | 2014 | 39 | 0.460 |
Why?
| | Appendicitis | 2 | 2023 | 124 | 0.450 |
Why?
| | MicroRNAs | 1 | 2020 | 677 | 0.430 |
Why?
| | Digestive System Diseases | 1 | 2013 | 25 | 0.420 |
Why?
| | Choledocholithiasis | 2 | 2023 | 14 | 0.420 |
Why?
| | Gallstones | 2 | 2023 | 31 | 0.420 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 51 | 0.410 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 73 | 0.410 |
Why?
| | Abdomen | 1 | 2013 | 116 | 0.410 |
Why?
| | Sarcoma | 3 | 2024 | 176 | 0.390 |
Why?
| | Infant | 14 | 2024 | 8914 | 0.390 |
Why?
| | Child Abuse | 2 | 2014 | 517 | 0.380 |
Why?
| | Internship and Residency | 1 | 2022 | 1048 | 0.380 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 535 | 0.380 |
Why?
| | Postoperative Complications | 3 | 2023 | 2485 | 0.370 |
Why?
| | Kidney Transplantation | 1 | 2017 | 602 | 0.360 |
Why?
| | Tissue Donors | 1 | 2013 | 388 | 0.350 |
Why?
| | Organ Transplantation | 1 | 2013 | 218 | 0.340 |
Why?
| | Retrospective Studies | 19 | 2024 | 14454 | 0.330 |
Why?
| | Humans | 42 | 2025 | 128417 | 0.330 |
Why?
| | Brain Injuries | 1 | 2014 | 463 | 0.330 |
Why?
| | Inflammation | 1 | 2020 | 2654 | 0.320 |
Why?
| | Wilms Tumor | 2 | 2022 | 77 | 0.320 |
Why?
| | Bile Ducts | 2 | 2020 | 67 | 0.320 |
Why?
| | Blood Substitutes | 1 | 2009 | 23 | 0.310 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 59 | 0.310 |
Why?
| | Child, Preschool | 12 | 2024 | 10384 | 0.300 |
Why?
| | Abdominal Abscess | 1 | 2007 | 26 | 0.290 |
Why?
| | Cellulitis | 1 | 2007 | 47 | 0.280 |
Why?
| | Drainage | 1 | 2007 | 164 | 0.270 |
Why?
| | Hemoglobins | 1 | 2009 | 336 | 0.270 |
Why?
| | Survival Rate | 4 | 2024 | 1869 | 0.270 |
Why?
| | Cytokines | 2 | 2018 | 1983 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2523 | 0.250 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2024 | 958 | 0.250 |
Why?
| | Laparoscopy | 3 | 2024 | 450 | 0.250 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 10 | 0.240 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 856 | 0.240 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 6 | 0.230 |
Why?
| | Mesenteric Veins | 1 | 2024 | 17 | 0.230 |
Why?
| | Adrenalectomy | 1 | 2024 | 66 | 0.230 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 26 | 0.210 |
Why?
| | Adolescent | 14 | 2024 | 20179 | 0.210 |
Why?
| | Pancreaticoduodenectomy | 1 | 2024 | 158 | 0.210 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 12 | 0.210 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 67 | 0.210 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 22 | 0.200 |
Why?
| | Sarcoma, Ewing | 1 | 2024 | 87 | 0.200 |
Why?
| | Documentation | 1 | 2024 | 181 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 97 | 0.200 |
Why?
| | Academic Medical Centers | 1 | 2025 | 476 | 0.190 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 20 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 19 | 0.190 |
Why?
| | Bone Neoplasms | 1 | 2024 | 229 | 0.190 |
Why?
| | Nephrectomy | 2 | 2022 | 158 | 0.180 |
Why?
| | Treatment Outcome | 5 | 2024 | 10151 | 0.180 |
Why?
| | CD79 Antigens | 1 | 2020 | 15 | 0.180 |
Why?
| | Thoracic Wall | 1 | 2020 | 18 | 0.180 |
Why?
| | Infant, Newborn | 5 | 2022 | 5687 | 0.170 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 35 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2024 | 2328 | 0.170 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 26 | 0.170 |
Why?
| | Cell Line | 2 | 2020 | 2731 | 0.170 |
Why?
| | Hepatocytes | 1 | 2020 | 213 | 0.160 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 96 | 0.160 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 215 | 0.150 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5362 | 0.150 |
Why?
| | Scoliosis | 1 | 2020 | 201 | 0.150 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 466 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2024 | 579 | 0.140 |
Why?
| | Critical Pathways | 1 | 2018 | 79 | 0.140 |
Why?
| | Job Satisfaction | 1 | 2019 | 201 | 0.140 |
Why?
| | Electronic Health Records | 1 | 2024 | 974 | 0.130 |
Why?
| | Male | 14 | 2024 | 62857 | 0.130 |
Why?
| | United States | 4 | 2024 | 13830 | 0.130 |
Why?
| | Postoperative Care | 1 | 2018 | 241 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2020 | 732 | 0.130 |
Why?
| | Female | 14 | 2024 | 68153 | 0.130 |
Why?
| | Perioperative Care | 1 | 2017 | 148 | 0.130 |
Why?
| | Liver | 2 | 2020 | 1826 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3937 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 33 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 887 | 0.110 |
Why?
| | Choledochal Cyst | 1 | 2013 | 16 | 0.110 |
Why?
| | Mice, Knockout | 1 | 2020 | 2755 | 0.110 |
Why?
| | Patient Selection | 1 | 2017 | 663 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 65 | 0.110 |
Why?
| | Bilirubin | 2 | 2023 | 92 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2024 | 1204 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 817 | 0.100 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 151 | 0.100 |
Why?
| | Forecasting | 1 | 2014 | 358 | 0.100 |
Why?
| | Preoperative Care | 1 | 2013 | 338 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2505 | 0.090 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2023 | 206 | 0.090 |
Why?
| | Mice | 3 | 2020 | 16602 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 6482 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1416 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2009 | 16 | 0.080 |
Why?
| | Enzyme Induction | 1 | 2009 | 89 | 0.080 |
Why?
| | Neoplasm Staging | 2 | 2023 | 1290 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 113 | 0.080 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 79 | 0.080 |
Why?
| | Length of Stay | 2 | 2018 | 1113 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2024 | 4892 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 9 | 0.070 |
Why?
| | Colorado | 2 | 2014 | 4375 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2007 | 44 | 0.070 |
Why?
| | Lymph | 1 | 2007 | 32 | 0.070 |
Why?
| | Registries | 1 | 2014 | 1877 | 0.070 |
Why?
| | Animals | 4 | 2020 | 34479 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2009 | 578 | 0.060 |
Why?
| | Tuberous Sclerosis | 1 | 1986 | 49 | 0.060 |
Why?
| | Databases, Factual | 2 | 2024 | 1269 | 0.060 |
Why?
| | Prognosis | 2 | 2024 | 3772 | 0.060 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 165 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 809 | 0.060 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2024 | 13 | 0.060 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.060 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 37 | 0.060 |
Why?
| | Induction Chemotherapy | 1 | 2024 | 70 | 0.060 |
Why?
| | Remission Induction | 1 | 2024 | 268 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 154 | 0.050 |
Why?
| | Lymphoma | 1 | 2024 | 194 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 85 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 4 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 17 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 64 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 17 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 44 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 150 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 86 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1986 | 367 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 23 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 664 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2023 | 165 | 0.050 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 43 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 381 | 0.050 |
Why?
| | Biopsy | 1 | 2024 | 1081 | 0.040 |
Why?
| | Universities | 1 | 2003 | 400 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 964 | 0.040 |
Why?
| | Risk-Taking | 1 | 2003 | 347 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 466 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 225 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 116 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 433 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1212 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 503 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 481 | 0.040 |
Why?
| | Students | 1 | 2003 | 572 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1663 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 304 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 157 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2547 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 507 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 815 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 345 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 803 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 429 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1228 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 608 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1559 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 12312 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2003 | 1275 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1263 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1142 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1664 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 60 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 301 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1258 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1974 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 3103 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7036 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 2680 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 47 | 0.020 |
Why?
| | Adult | 3 | 2023 | 35299 | 0.020 |
Why?
| | Rupture, Spontaneous | 1 | 1986 | 20 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 134 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 1986 | 30 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 335 | 0.020 |
Why?
| | Actins | 1 | 2007 | 401 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2007 | 659 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 40 | 0.010 |
Why?
| | Aged | 1 | 2022 | 21953 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2239 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 151 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 150 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 1009 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 647 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 232 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5165 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|